baber/WOPTO huggingface dataset:
Patent CY-1113201-T1 (CY)
Inventor: THONI LOTHAR
IPC: F16L23/024
Filed: 2012-07-20
Abstract: The component (1), particularly a pipe or a housing part, has a pipe section (4) and a flange (2) provided with a flange support (3). A groove is arranged between the flange support and the pipe section. The groove runs around a longitudinal axis (L) of the flange. The groove is filled by a filling bore (8) with a sealing unit for producing a cohesive sealed pressure connection. An independent claim is also included for a method for producing a compressed gas-proof connection between a component, particularly a pipe or a housing part, and a flange.
Patent CY-1116153-T1 (CY)
Title: Ιος συνδρομου πολυσυστηματικης απισχνανσεως μετα τον απογαλακτισμο απο χοιρους
Inventor: WANG LI
IPC: C12Q1/68
Filed: 2015-01-02
Abstract: Περιγράφεται η κλωνοποίηση ενός νέου γονιδιώματος του ιού PCVII, καθώς και η έκφραση πρωτεϊνών προερχόμενων από το γονιδίωμα του PCVII. Αυτές οι πρωτεΐνες μπορούν να χρησιμοποιηθούν σε συνθέσεις εμβολίων για την πρόληψη και την αγωγή μολύνσεων από PVCII, καθώς και σε διαγνωστικές μεθόδους για τον προσδιορισμό της παρουσίας μολύνσεων από τον PCVII σε ένα σπονδυλωτό άτομο. Τα πολυνουκλεοτίδια που προέρχονται από το γονιδίωμα του ιού μπορούν να χρησιμοποιηθούν ως διαγνωστικοί εκκινητές και ιχνηλάτες.
Patent CY-1116409-T1 (CY)
Title: ΜΕΙΩΣΗ β-ΚΥΤΤΑΡΩΝ ΜΕ ΤΗ ΧΡΗΣΗ CD37-ΕΙΔΙΚΩΝ ΚΑΙ CD20-ΕΙΔΙΚΩΝ ΜΟΡΙΩΝ ΔΕΣΜΕΥΣΗΣ
Inventor: GROSMAIRE LAURA SUE
IPC: C07K16/46
Filed: 2015-06-05
Abstract: Η παρούσα αίτηση γενικά παρέχει μεθόδους για τη μείωση των β-κυττάρων σε ένα άτομο, με τη χρήση CD37-ειδικών μορίων δέσμευσης. Συγκεκριμένα, η εφεύρεση παρέχει μεθόδους για τη μείωση των β-κυττάρων με τη χρήση CD37-ειδικών μορίων δέσμευσης μόνων, ή συνδυασμού CD37-ειδικών μορίων δέσμευσης και CD20-ειδικών μορίων δέσμευσης, σε κάποιες περιπτώσεις ενός συνεργιστικού συνδυασμού. Η αίτηση επιπλέον παρέχει υλικά και μεθόδους για τη θεραπευτική αγωγή νόσων, οι οποίες περιλαμβάνουν ανώμαλη β-κυτταρική δραστικότητα. Επιπλέον, η αίτηση παρέχει ανθρωποποιημένα CD37-ειδικά μόρια δέσμευσης.
Patent CY-1116693-T1 (CY)
Title: Συνδυασμος αζελαστινης και κυκλεσονιδης
Inventor: LULLA AMAR
IPC: A61K31/55
Filed: 2015-09-16
Abstract: Φαρμακευτική συνταγοποίηση η οποία περιλαμβάνει αζελαστίνη και φαρμακευτικώς αποδεκτό άλας, διαλύτωμα ή φυσιολογικώς λειτουργικό παράγωγο αυτής και κυκλεσονίδη.
Patent CY-1118684-T1 (CY)
Title: Διαδερμικα επιθεματα χαμηλης δοσης με υψηλη απελευθερωση φαρμακου
Inventor: TEREBESI ILDIKO
IPC: A61K31/57
Filed: 2017-03-01
Abstract: Η παρούσα εφεύρεση αφορά στον τομέα των τεχνικών για φαρμακοτεχνικές μορφές. Η εφεύρεση παρέχει μια φαρμακευτική σύνθεση χαμηλής δόσης για τη διαδερμική χορήγηση ορμονών, κατά προτίμηση μιας προγεστερόνης, όπως η Γεστοδένη, και ενός οιστρογόνου, κατά προτίμηση Αιθινυλοιστραδιόλη ώστε να επιτευχθούν προφίλ συγκέντρωσης πλάσματος αποτελεσματικά για την παρεμπόδιση της ωορρηξίας σε μια γυναίκα.
Patent CY-1118880-T1 (CY)
Title: Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
Inventor: BENSON JACQUELINE
IPC: G01N33/567
Filed: 2017-05-04
Abstract: Ένα ανθρώπινο αντι-IL-23p19 αντίσωμα, συμπεριλαμβανομένων απομονωμένων νουκλεϊνικών οξέων που κωδικοποιούν τουλάχιστον ένα αντι-IL-23p19 αντίσωμα, φορείς, κύτταρα ξενιστές και μέθοδοι παρασκευής και χρήσης αυτών έχουν εφαρμογή σε διαγνωστικές και/ή θεραπευτικές συνθέσεις, μεθόδους και συσκευές.
Patent CY-1119878-T1 (CY)
Title: Μια μεθοδος για απομονωση πυρηνικων οξεων και ενα kit εξ' αυτης
Inventor: PULLELA PHANI KUMAR
IPC: C12N15/10
Filed: 2017-11-23
Abstract: Η παρούσα αποκάλυψη παρέχει μια μέθοδο για απομόνωση φυσικών & τεχνητών πυρηνικών οξέων όπως τα δεοξυριβονουκλεϊκό οξύ (DNA), ριβονουκλεϊκό οξύ (RNA) και πυρηνικό οξύ πεπτιδίων (ΡΝΑ) από ένα στερεό ή υγρό δείγμα χρησιμοποιώντας βάμβακα. Ο βάμβαξ που συσκευάζεται είναι έτσι ώστε, ένα διάλυμα που περιέχει πυρηνικά οξέα να διέρχεται μέσα από αυτόν και τα πυρηνικά οξέα σε διάλυμα να δεσμεύονται στον βάμβακα σε ένα βέλτιστο μέσο για δέσμευση. Τα πυρηνικά οξέα δεσμεύονται σε βάμβακα κατά τέτοιο τρόπο ώστε, τα δεσμευθέντα πυρηνικά οξέα να μπορούν να αντέξουν πολλαπλές πλύσεις με υγρό περιλαμβάνοντας ύδωρ και που να εκλούονται σε ένα υδατικό ρυθμιστικό, με το οποίο τα εκλουσθέντα πυρηνικά οξέα να μπορούν να χρησιμοποιηθούν άμεσα για ενίσχυση χρησιμοποιώντας PCR ή για τις οποιεσδήποτε άλλες βιοχημικές ανάγκες ή ανάγκες μοριακής βιολογίας.
Patent CY-1120414-T1 (CY)
Title: Αντισωματα που συνδεονται me οχ40 και οι χρησεις τους
Inventor: ATTINGER ANTOINE
IPC: C07K16/28
Filed: 2018-07-11
Abstract: Η παρούσα εφεύρεση σχετίζεται με αντισώματα ανταγωνιστές ή τμήματα αυτών που συνδέονται με ανθρώπινο ΟΧ40. Περισσότερο συγκεκριμένα, η παρούσα εφεύρεση σχετίζεται με ένα αντίσωμα ανταγωνιστή ή τμήμα αυτού που συνδέεται με ανθρώπινο ΟΧ40 και περιλαμβάνει μια CDR1 βαριάς αλυσίδας που περιλαμβάνει την αλληλουχία αμινοξέων της SEQ ID NO: 1, ή/και μια CDR2 βαριάς αλυσίδας που περιλαμβάνει την αλληλουχία αμινοξέων της SEQ ID NO: 2, ή/και μια CDR3 βαριάς αλυσίδας που περιλαμβάνει την αλληλουχία αμινοξέων της SEQ ID NO: 3· ή/και το οποίο περιλαμβάνει μια CDR1 ελαφριάς αλυσίδας που περιλαμβάνει την αλληλουχία αμινοξέων της SEQ ID NO: 4, ή/και μια CDR2 ελαφριάς αλυσίδας που περιλαμβάνει την αλληλουχία αμινοξέων της SEQ ID NO: ή/και μια CDR3 ελαφριάς αλυσίδας που περιλαμβάνει την αλληλουχία αμινοξέων της SEQ ID NO: 6.
Patent CY-1122643-T1 (CY)
Title: Διαταξη συγκεντρωσης για εnιαιους ή πολλαπλους περιεκτες
Inventor: SCHWEISS MARK DAVID
IPC: A61J1/20
Filed: 2019-07-16
Abstract: Παρέχεται μια διάταξη (10) για τη συγκέντρωση ενός ρευστού από μια μονάδα περιέκτη (12) που έχει τουλάχιστον έναν περιέκτη (14, 16), και περιλαμβάνει μια θύρα εισόδου (18) που διαθέτει τουλάχιστον ένα κανάλι εισόδου (22, 24) διαμορφωμένο να υποδέχεται το ρευστό ή τον περιβάλλοντα αέρα, και μια θύρα εξόδου (26) που διαθέτει τουλάχιστον ένα κανάλι εξόδου (32, 34) διαμορφωμένο για να χορηγεί το ρευστό σε ένα προσάρτημα. Τόσο η θύρα εισόδου όσο και εξόδου (18, 26) είναι τοποθετημένες πάνω στη διάταξη (10). Παρέχεται μια κοιλότητα (40) για την υποδοχή της εισαγωγής της μονάδας περιέκτη (12) για τη συγκέντρωση του ρευστού από τον τουλάχιστον έναν περιέκτη (14, 16). Τουλάχιστον μια ακίδα διατίθεται στην κοιλότητα και είναι διαμορφωμένη για να διατρυπά ένα κάλυμμα (44, 46) του τουλάχιστον ενός περιέκτη, όταν η μονάδα περιέκτη μεταβαίνει από μια ανώτερη θέση σε μια κατώτερη θέση.
Patent CY-1124638-T1 (CY)
Title: Ενωσεις κυκλικων δινουκλεοτιδιων
Inventor: OOST THORSTEN
IPC: C07H21/02
Filed: 2021-02-08
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ενώσεις του γενικού τύπου (Ι), όπου οι ομάδες R1, R2 και R3 ορίζονται όπως στην αξίωση 1, οι οποίες έχουν πολύτιμες φαρμακολογικές ιδιότητες, συγκεκριμένα είναι διαμορφωτές του STING.
Patent CY-1124904-T1 (CY)
Title: Τυροθρικινη για χρηση στην αγωγη ή προληψη σωματικων οσμων καθως και παρασκευασματα γι'αυτην
Inventor: LEIBBRAND THOMAS
IPC: A61K8/42
Filed: 2022-01-10
Abstract: Περιγράφεται η θεραπευτική ή η μη-θεραπευτική χρήση της τυροθρικίνης για την αγωγή και/ή πρόληψη σωματικών οσμών σε ανθρώπους, κατά προτίμηση μέσω τοπικής, επιφανειακής εφαρμογής και/ή κατά προτίμηση μέσω εφαρμογής στο άθικτο δέρμα και/ή βλεννογόνο. Περαιτέρω περιγράφεται θεραπευτική, κατά προτίμηση φαρμακευτική, ή μη-θεραπευτική, κατά προτίμηση καλλυντική, σύνθεση, περιέχουσα τυροθρικίνη και κερατολυτικό παράγοντα, για την αγωγή και/ή πρόληψη σωματικών οσμών σε ανθρώπους. Επίσης περιγράφεται κιτ, περιέχον τυροθρικίνη και κερατολυτικό παράγοντα, καθώς και αντικείμενο υπόδησης το οποίο περιέχει τυροθρικίνη.
Patent SI-1212081-T1 (SI)
Title: Use of ace inhibitors in the prevention of congestive heart failure
Inventor: SCHOELKENS BERNWARD
IPC: A61K38/00
Filed: 2000-08-25
Abstract: Novel use of an inhibitor of the renin-angiotensin system or derivative (I) in the manufacture of a medicament for the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. Independent claims are also included for: a method of preventing of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF; and a formulation for use in the prevention of stroke in patients exhibiting normal or low blood pressure, diabetes and/ or congestive heart failure (CHF) with no pre-existing CHF. ACTIVITY : Cerebroprotective; Cardiant; Antidiabetic. Treating 9,541 patients who are at risk for cardiovascular events due to a history of previous ischemic heart disease, stroke, peripheral arterial disease or individuals with diabetes with ramipril for 6 years resulted in a 32% reduction in the number of patients who developed a stroke, 21% who developed congestive heart failure, and 36% reduction who developed diabetes. MECHANISM OF ACTION : Angiotensin converting enzyme (ACE) inhibitor; an angiotensin II antagonist.
Patent SI-1613740-T1 (SI)
Title: Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
Inventor: MOLIN GORAN
IPC: A23L33/00
Filed: 2004-04-02
Abstract: A composition (I), comprises one or more tannase-producing strains of Lactobacillus plantarum or closely related Lactobacillus species having the ability to adhere to human intestinal mucosa in combination with tannin. An independent claim is also included for a tannase-producing strain (II) of L.plantarum or a closely related Lactobacillus species having the ability to adhere to the human intestinal mucosa, with tannase activity as determined by Osawa and Walsh, excluding the strains L.plantarum 299, DSM 6595, and L.plantarum 299v, DSM 9843. ACTIVITY : Cardiovascular-Gen.; Antidiabetic; Antiinflammatory; Gastrointestinal-Gen.; Cytostatic; Neuroprotective; Nootropic; Immunosuppressive. No supporting data is given. MECHANISM OF ACTION : None given.
Patent SI-1948387-T1 (SI)
Title: Nozzle for emitting solid carbon dioxide particles with an axially displaceable valve member; apparatus for cooling a heated weld zone with such a nozzle; welding apparatus with such cooling apparatus
Inventor: JOHNSON ANDREW NEIL
IPC: B23K26/20
Filed: 2006-10-23
Abstract: The invention relates to a nozzle (16) for emitting solid carbon dioxide particles. The nozzle (16) comprising an inlet (30) for receiving liquid carbon dioxide, a nozzle aperture (32) from which solid carbon dioxide particles flow from the nozzle (16), a duct extending between the inlet (30) and the nozzle aperture (32), the duct having a convergent section (36) and a divergent section (38), and an axially displaceable valve member (42) located within the duct, the valve member (42) having first and second convergent portions and a substantially cylindrical portion located between the first and second convergent portions. The nozzle (16) finds particular use in apparatus for cooling a heated weld zone in a workpiece.
Patent SI-3124203-T1 (SI)
Title: Process for making pet containers with enhanced thermal properties
Inventor: SILVERS KERRY W
IPC: B29C49/00
Filed: 2011-12-15
Abstract: A blow-molded PET container comprising a wall having a density of between about 1.370 g/cc and 1.385 g/cc, a heat-induced crystallinity of from about 18% to about 25%, and a strain-induced crystalinity of from about 55% to about 75%, wherein the PET container, when filled with a liquid having a temperature of from about 100°C to about 132°C or when subjected to a pasteurization or retort process, will not experience a change in volume of greater than 3%.
Patent TR-200604930-T1 (TR)
Title: Bir bulaşık makinası ve kontrol yöntemi.
Inventor: UZ ATILLA
IPC: A47L15/46
Filed: 2005-03-16
Abstract: Bu buluş, sirkülasyon pompasının (4) şebekeden çektiği akım (I) izlenerek, yıkama performansını olumsuz olarak etkileyen filtre tıkanması, rotor kilitlenmesi, köpüklenme veya viskozite artışı gibi etkenlerin teşhis edildiği ve tespit edilen problemin giderilmesi için çözüm adımlarının uygulandığı bir bulaşık makinası (1) ve kontrol yöntemi ile ilgilidir.
Patent DE-3782132-T2 (DE)
Inventor: LACRUCHE BERNARD
IPC: A61B17/22
Filed: 1987-06-29
Granted: 1993-05-06
Abstract: The apparatus comprises a device (4) for generating high-frequency shock waves by electric discharge between at least two electrodes (6, 8) which are arranged at least partly in a chamber (10) filled with liquid (2) and are supplied intermittently with electric current, advantageously from an electric current source by way of a supply connection (12), the generating device (4) allowing the shock waves to be focused on the target. The apparatus is characterised in that the connection (12) for supplying the electrodes (6, 8) with electric current is arranged inside an essentially closed tubular element (16) in order to limit or prevent the electromagnetic losses. This tubular element (16) is preferably mounted displaceable at any point in space relative to the framework (50) and supports the device (4) for generating shock waves. 
<??>The apparatus makes it possible to limit or prevent the electromagnetic losses and thus enhances the safety of the patients. 
<IMAGE>
Patent DE-3851190-T2 (DE)
Inventor: RAMSAY MICHAEL V J
IPC: C07H19/01
Filed: 1988-09-09
Granted: 1995-01-12
Abstract: Compounds of formula (I) <CHEM> and salts thereof, wherein R<1> represents a methyl, ethyl or isopropyl group; R<2> represents a C2-7 alkyl group interrupted by an oxygen or sulphur atom or an aryl, aryl C1-7 alkyl or heteroaryl C1-7 alkyl group; OR<3> is a hydroxyl group or a substituted hydroxyl group having up to 25 carbon atoms; and the group =NOR<2> is in the E configuration. These compounds may be used for controlling insect, acarine, nematode or other pests.
Patent DE-3851520-T2 (DE)
Inventor: PEYRET OLIVIER
IPC: G21K1/10
Filed: 1988-11-10
Granted: 1995-04-20
Abstract: The invention relates to a mammographic apparatus (1) making it possible to produce negatives of breasts of medium to large size and/or medium to high density with the aid of a receiver (86) of the intensifying screen/film pair type, without increasing the dose absorbed by the patient or degrading the quality of the negatives compared to the negatives produced for such breasts with the aid of X- radiation emitted by a molybdenum target (20) and molybdenum filter. For this purpose, the mammographic apparatus according to the invention comprises an X-ray tube (6) whose anode (9) is provided with a rhodium target (21). <IMAGE>
Patent DE-3854601-T2 (DE)
Inventor: HIRASE IKUO
IPC: B01D53/64
Filed: 1988-11-28
Granted: 1996-04-04
Abstract: Device for trapping the gaseous compounds of refractory metals, characterised in that it comprises at least one vessel (1) of elongate shape arranged vertically, made up of a hollow cylindrical body (2) closed in a leakproof manner by a lid (4) in its upper part and by a hollow bottom (5) in its lower part, the said vessel being packed over most of the height of the body with a thermally conductive packing (10) leaving within it free vertical spaces from the top downwards; the said vessel comprising an entry orifice (8) for the gases below the bottom of the packing and an exit orifice (11) for the gases above the packing; the said vessel comprising in its top part an exit orifice for the gases and in its bottom part an orifice for introducing gases; the said vessel being provided with heating means (6, 7) and optionally with thermal insulation. 
<??>The invention also relates to a gas pumping plant in a process using refractory metal compounds comprising such a device. 
<IMAGE>
Patent DE-3854956-T2 (DE)
Inventor: URDEA MICHAEL S
IPC: C12Q1/68
Filed: 1988-10-17
Granted: 1996-06-13
Abstract: Linear or branched oligonucleotide multimers useful as amplifiers in biochemical assays which comprise (1) at least one first single-stranded oligonucleotide unit that is complementary to a single-stranded oligonucleotide sequence of interest, and (2) a multiplicity of second single-stranded oligonucleotide units that are complementary to a single-stranded labelled oligonucleotide. Amplified sandwich nucleic acid hybridization and immunoassays using the multimers are exemplified.
Patent DE-3872399-T2 (DE)
Inventor: LINCH RAYMOND
IPC: A47F5/00
Filed: 1988-12-05
Granted: 1993-02-11
Abstract: An elongate separating member comprises an elongate extruded channel (6) supported mouth upwards by web (5) over base (4) and a moulded bar (2) slidable in the channel e.g. beneath retention lips (9). This bar is trapezoidal in cross-section to facilitate sliding, and is provided with through holes (17) at intervals. Holes (17) hold the stems (16) of sprigs (3) of artificial vegetation, each stem being secured by a melted and resolidified end stud (18) which does not detrimentally affect sliding. The whole assembly fits between the edges (19, 20) of display trays in e.g. a butchers display counter. For hygienic cleaning the bars (2) and sprays (3) can be slid out and boiled; the extruded channel unit (4, 5, 6) can be more suitably cleaned without heat distortion.
Patent DE-3873437-T2 (DE)
Inventor: ROBINSON JACK B JR
IPC: C12Q1/44
Filed: 1988-06-21
Granted: 1992-12-03
Abstract: A reagent system for determining serum lipase which comprises lipid particles having a diameter of less than 0.5 microns. The reagent system has improved stability against sedimentation and coalescence. A turbidimetric method for the determination of serum lipase is also disclosed wherein a serum sample is added to a suspension of lipid particles having a diameter of less than 0.5 microns and the amount of lipase present in the serum sample is determined by measuring a change in the turbidity of the suspension.
Patent DE-3881273-T2 (DE)
Inventor: RICHARDSON PETER JOHN
IPC: C09D5/08
Filed: 1988-04-11
Granted: 1993-09-09
Abstract: A composition which comprises (a) a salt of a metal (M) of a hydroxycarboxylic acid in which the OH and COOH groups are attached to the ring atoms of a fused ring system and (b) a surface coating compound or composition. The metal (M) is at least divalent and may be magnesium, calcium, barium or particularly zinc. The fused ring system is preferably a fused aromatic hydrocarbon ring system such as naphthalene. The OH and COOH groups can be attached to adjacent carbon atoms of fused hydrocarbon ring system. Zinc 3-hydroxy-2-naphthoate has been found to be particularly suitable. The composition may also include a metal oxide and/or a metal phosphate. Component (b) can be a film forming binder system, a natural oil or a grease. The composition can be coated onto the surface of a metal. The coated metal shows improved resistance to corrosion.
Patent DE-3881337-T2 (DE)
Inventor: BAGGIO GIORGIO
IPC: A43B3/35
Filed: 1988-10-24
Granted: 1993-09-02
Abstract: A heating device for ski boots comprising an insole (3), provided with an electric resistor (5) and temporarily associable with the boot, below which there is rigidly associated a rigid inner sole (6) having, preferably at the heel region (7), an accommodation (9) for one or more accumulators (10). Electric conductors (11) are furthermore provided which extend from the insole and are connected to a support (16), provided with at least one switch (17), temporarily associable with one of the components of the ski boot.
Patent TR-199801378-T2 (TR)
Inventor: KOCH REINHARD
IPC: C02F3/12
Filed: 1997-01-27
Abstract: The invention concerns a small-scale biological sewage treatment plant operated by fluid bed/biofilm technology for treating waste water. According to the invention, for the biological/biofilm treatment of the activated sludge a biostage (2) with an aeration device (4) which can be switched off is arranged downstream of a preliminary sedimentation tank with a sludge reservoir (1) and a feed pipe (6). The biostage (2) is partially filled with growth bodies (5) having a colonizable area of at least 800 m<2> per m<3> of bulk volume and comprises a retention device (8) for retaining the growth bodies (5) in an obstruction-free manner. Disposed after the retention device (8) is a final sedimentation tank (3) which can be flowed through vertically and has a discharge (7), the parts of the plant (1 to 4) preferably being disposed in circular tanks. The retention device (8) can consist of a pipe in or over which a discharge pipe leads into the final sedimentation tank (3). The biostage (2) can further comprise a biofilter stage (9) into which lead the feed pipe from the preliminary sedimentation tank (1) and the feed pipe for returned sludge from the final sedimentation tank (3). The specific weight of the growth bodies can be greater or less than 1.0 g/cm<3>.
Patent TR-199802168-T2 (TR)
Inventor: KURTH REINHARD
IPC: A61P29/00
Filed: 1997-04-30
Abstract: Bir prokaryotik veya ökaryotik konak hücre içinde interlökin-16 aktivitesine sahip bir polipeptidin ekspresyonunu yapmak için kullanilabilen bir nükleik asit olup, burada söz konusu nükleik asit, Dizi tanim nO: 2'deki veya N-terminalinde bir aspartik asit kalintisi ile uzatilmis veya C-terminalinde 8 taneye kadar amino asidi kisaltilmis haldeki bir Dizi tanim no: 2'ye ait amino asit dizimine sahip bir polipeptid için kodlama yapar ve aktif IL-16 polipeptidi üretimi için uygundur.
Patent DE-60000972-T2 (DE)
Inventor: DUSSAUBY MARIE-PIERRE
IPC: H03B5/18
Filed: 2000-02-04
Granted: 2003-08-28
Abstract: A voltage-controlled oscillator including a dielectric resonator having a ferroelectric ceramic material placed between two metallized surfaces and biased by an electric field created by a difference in potential applied between the two surfaces as a function of a tuning frequency of the oscillator. Also included is a load impedance, and an active amplifier element coupled between the dielectric resonator and the load impedance. Further, the ceramic material is formed by metal oxides of the family: Bax;Sr(1-x) Ti(1-y)(A)y O3 (1) in which: A is a constituent configured to reduce dielectric losses of the material, and -0.4≲x≲0.9-0.001≲y≲0.2.
Patent DE-60004368-T2 (DE)
Inventor: EIJKELHOF ROGIER
IPC: H04N1/393
Filed: 2000-05-25
Granted: 2004-06-24
Abstract: In a method for processing data in the form of a grid of discrete source values, at least one target value situated among the source values is determined by means of interpolation. According to the invention account is also taken of the character and the definition of the source data by determining a local minimum and a local maximum of the surrounding source values in a region round the target value for determining and by determining a measure for the dynamics of the surrounding source values in a region round the target value to be determined. The target value calculated by interpolation is adjusted in the direction of either the local maximum or the local minimum on the basis of the thus calculated measure for the dynamics of the surrounding source values in order to express the character and the definition of the source data.